Comparison of sarcoidosis phenotypes among affected African-American siblings

Chest

Volumn 130, Issue 3, 2006, Pages 855-862

  Judson, Marc A ^a,m   Hirst, Kathryn ^b   Iyengar, Sudha K ^c   Rybicki, Benjamin A ^d   El Ghormli, Laure ^b   Baughman, Robert P ^e   Donohue, James F ^f   Elston, Robert C ^c   Kavuru, Mani S ^g   Moller, David R ^h   Newman, Lee S ⁱ   Rabin, David L ^j   Rossman, Milton D ^k   Teirstein, Alvin S ^l   Iannuzzi, Michael C ^l  

^a MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^b GEORGE WASHINGTON UNIVERSITY   (United States)

^c CASE WESTERN RESERVE UNIVERSITY   (United States)

^d HENRY FORD HEALTH SYSTEM   (United States)

^e UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

^f UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^g LERNER RESEARCH INSTITUTE   (United States)

^h JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

ⁱ NATIONAL JEWISH MEDICAL AND RESEARCH CENTER   (United States)

^j GEORGETOWN UNIVERSITY   (United States)

^k HOSPITAL OF THE UNIVERSITY OF PENNSYLVANIA   (United States)

^l MOUNT SINAI MEDICAL CENTER   (United States)

^m MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

more..

Author keywords

Genetics; Phenotype; Sarcoidosis; Sibling

Indexed keywords

AFRICAN AMERICAN; ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; EYE; HUMAN; LIVER; LUNG FUNCTION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; OUTCOME ASSESSMENT; PHENOTYPE; PRIORITY JOURNAL; RISK ASSESSMENT; SARCOIDOSIS; SIBLING;

EID: 33748855564     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.130.3.855     Document Type: Article

References (25)

1. American Thoracic Society/European Respiratory Society. Statement on sarcoidosis. Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (RS) and the World Association of Sarcoidosis and Other Granulomatous Diseases (WASOG) adopted by the ATS Board of Directors and the ERS Executive Committee, February 1999. Am J Respir Crit Care Med 1999; 160:736-755
2. Johns CJ, Michele TM. The clinical management of sarcoidosis: a 50-year experience at the Johns Hopkins Hospital. Medicine 1999; 78:65-111
3. Costabel U. Sarcoidosis: clinical update. Eur Respir J 2001; 18(suppl):56s-68s
4. Judson MA, Baughman RP, Teirstein AS, et al. Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. Sarcoidosis Vasc Diffuse Lung Dis 1999; 16:75-86
5. Rybicki BA, Iannuzzi MC, Frederick MM, et al. Familial aggregation of sarcoidosis: A Case-Control Etiologic Study of Sarcoidosis (ACCESS). Am J Respir Crit Care Med 2001; 164:2085-2091
6. Harrington, DW, Major, M, Rybicki, B, et al. Familial analysis of 91 families. Sarcoidosis 1994; 11(suppl):240-243
7. Iannuzzi MC, Iyengar SK, Gray-McGuire C, et al. Genome wide search for sarcoidosis susceptibility genes in African Americans. Genes Immun 2005; 6:509-518
8. Rybicki BA, Hirst K, Iyengar SK, et al. A sarcoidosis genetic linkage consortium: the Sarcoidosis Genetic Analysis (SAGA) Study. Sarcoidosis Vasc Diffuse Lung Dis 2005; 22:115-122
9. Siltzbach LE. Sarcoidosis: clinical features and management. Med Clin North Am 1967; 51:480-502
10. Hankinson JL, Odencrantz JR, Fedan KB. Spirometric reference values from a sample of the general US population. Am J Respir Crit Care Med 1999; 159:179-187
11. Fleiss JL. Statistical methods for rates and proportions, 2nd ed. New York, NY: Wiley, 1981
12. Trojano M, Liguori M, De Robertis F, et al. Comparison of clinical and demographic features between affected pairs of Italian multiple sclerosis multiplex families: relation to tumour necrosis factor genomic polymorphisms. J Neurol Sci 1999; 162:194-200
13. Silman AJ, Ollier W, Currey HLF. Failure to find disease similarity in sibling pairs with rheumatoid arthritis. Annals Rheum Dis 1987; 46:135-138
14. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med 1997; 336:1224-1234
15. Sartwell PE, Edwards LB. Epidemiology of sarcoidosis in the US Navy. Am J Epidemiol 1974; 99:250-257
16. Israel HL, Karlin P, Menduke H. Factors effecting outcome of sarcoidosis: influence of race, extrathoracic involvement, and initial radiologic lesions. Ann NY Acad Sci 1986; 465:609-618
17. Gottlieb JE, Israel HL, Steiner RM, et al. Outcome in sarcoidosis: the relationship of relapse to corticosteroid therapy. Chest 1997; 111:623-631
18. Judson MA, Baughman RP, Thompson BW, et al. Two year prognosis of sarcoidosis: the ACCESS experience. Sarcoidosis Vasc Diffuse Lung Dis 2003; 20:204-211
19. Sharma OP, Johnson CS, Balchum OJ. Familial sarcoidosis: report of four siblings with acute sarcoidosis. Am Rev Respir Dis 1971; 104:255-257
20. Brennan NJ, Crean P, Long JP, et al. High prevalence of familial sarcoidosis in an Irish population. Thorax 1984; 39:14-18
21. Nassif X, Valeyre D, Loiseau A, et al. Familial sarcoidosis: apropos of 22 families [in French]. Ann Med Interne 1985; 136:611-614
22. Grunewald J, Janson CH, Ekland A, et al. Restricted Vαβ2,3 gene usage by CD4+ T lymphocytes in bronchoalveolar lavage fluid from sarcoidosis patients correlates with HLA-DR#. Eur J Immunol 1992; 22:129-135
23. Schurmann M, Reichel P, Muller-Myhsok B, et al. Results from a genome-wide search for predisposing genes in sarcoidosis. Am J Respir Crit Care Med 2001; 164:840-846
24. Lynch JP, Kazerooni EA, Gay SE. Pulmonary sarcoidosis. Clin Chest Med 1997; 18:755-785
25. Baughman RP, Teirstein AS, Judson MA, et al. Case Control Etiologic Study of Sarcoidosis (ACCESS) research group. Clinical characteristics of patients in a case control study of sarcoidosis. Am J Respir Crit Care Med 2001; 164:1885-1889